BIOFIL CHEMICALS & PHARMACEUTICALS LTD. Q4 FY25 Results
BIOFILCHEMQ4 FY25 ResultsAnnounced 30 May 2025, 06:36 pm| Metric | Value (₹ Cr) | vs Q3 FY25 |
|---|---|---|
| Revenue | 8.35 | 41.2% |
| Total Income | 8.59 | 39.6% |
| Expenditure | 8.33 | 40.5% |
| PBT | 0.25 | 14.3% |
| Net Profit | 0.20 | 21.0% |
| OPM | 1.29% | 0.66pp |
| NPM | 2.32% | 1.16pp |
| EPS | 0.12 | 20.0% |
Biofil Chemicals & Pharmaceuticals Ltd. Reports FY2024-25 Financial Results with 55.78% YoY Profit Growth
30 May 2025 · 30 May 2025, 06:58 pm
Summary
Biofil Chemicals & Pharmaceuticals Ltd. has reported a 55.78% YoY profit growth for the financial year 2024-25. The company's revenue from operations stands at INR 3370.74 lakhs for the year ended 31st March 2025. The profit for the period is INR 70.92 lakhs. The company operates within India and has two business segments: Pharma Division and Chemicals Division.
Key Highlights
- 1
FY2024-25 revenue from operations: INR 3370.74 lakhs
- 2
Profit for the period: INR 70.92 lakhs
- 3
55.78% YoY profit growth
- 4
Two business segments: Pharma Division and Chemicals Division
Management Comments
Apoorv Jain
The aforesaid Audited Financial Results for the Quarter and financial year ended March 31, 2025 were reviewed and recommended by the Audit Committee and approved by the Board of Directors in it's meeting held on 30th May 2025. The above results have been audited by 1 statutory Auditors of the company in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company's Management has exercised necessary due diligence to ensure that the financial results provide a true and fair view of its affairs.
Informational and educational content only. Not investment advice.